Trademark: 88517411
Word
I-MAB BIOPHARMA
Status
Registered
Status Code
700
Status Date
Tuesday, January 25, 2022
Serial Number
88517411
Registration Number
6629613
Registration Date
Tuesday, January 25, 2022
Mark Type
3000
Filing Date
Tuesday, July 16, 2019
Published for Opposition
Tuesday, September 7, 2021

Trademark Owner History
I-MAB BIOPHARMA CO., LTD -
I-MAB - Original Registrant

Classifications
5 Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
42 Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
The mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B". Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters. The color white appearing in the mark represents transparent space and is not a part of the mark.
The color(s) blue, dark blue, green, and light green is/are claimed as a feature of the mark.
"BIOPHARMA"

Trademark Events
May 17, 2023
Automatic Update Of Assignment Of Ownership
Jan 25, 2022
Registered-Principal Register
Dec 24, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 23, 2021
Allowed Principal Register - Sou Accepted
Dec 23, 2021
Examiner's Amendment Entered
Dec 23, 2021
Notification Of Examiners Amendment E-Mailed
Dec 23, 2021
Examiners Amendment E-Mailed
Dec 23, 2021
Su-Examiner's Amendment Written
Dec 21, 2021
Statement Of Use Processing Complete
Nov 12, 2021
Use Amendment Filed
Dec 13, 2021
Case Assigned To Intent To Use Paralegal
Nov 12, 2021
Teas Statement Of Use Received
Nov 2, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 2, 2021
Assigned To Lie
Aug 2, 2021
Approved For Pub - Principal Register
Jul 30, 2021
Teas/Email Correspondence Entered
Jul 29, 2021
Correspondence Received In Law Office
Jul 29, 2021
Teas Response To Office Action Received
Jul 1, 2021
Notification Of Non-Final Action E-Mailed
Jul 1, 2021
Non-Final Action E-Mailed
Jul 1, 2021
Non-Final Action Written
Jun 4, 2021
Teas/Email Correspondence Entered
Jun 3, 2021
Correspondence Received In Law Office
Jun 3, 2021
Teas Response To Suspension Inquiry Received
Apr 13, 2021
Report Completed Suspension Check Case Still Suspended
Oct 13, 2020
Report Completed Suspension Check Case Still Suspended
Apr 9, 2020
Notification Of Letter Of Suspension E-Mailed
Apr 9, 2020
Letter Of Suspension E-Mailed
Apr 9, 2020
Suspension Letter Written
Mar 11, 2020
Teas/Email Correspondence Entered
Mar 10, 2020
Correspondence Received In Law Office
Mar 10, 2020
Teas Response To Office Action Received
Oct 24, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 24, 2019
Teas Change Of Owner Address Received
Sep 12, 2019
Notification Of Non-Final Action E-Mailed
Sep 12, 2019
Non-Final Action E-Mailed
Sep 12, 2019
Non-Final Action Written
Sep 10, 2019
Assigned To Examiner
Jul 24, 2019
Notice Of Design Search Code E-Mailed
Jul 23, 2019
New Application Office Supplied Data Entered
Jul 19, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24